These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33937590)

  • 1. Leukocyte/platelet hybrid membrane-camouflaged dendritic large pore mesoporous silica nanoparticles co-loaded with photo/chemotherapeutic agents for triple negative breast cancer combination treatment.
    Zhang T; Liu H; Li L; Guo Z; Song J; Yang X; Wan G; Li R; Wang Y
    Bioact Mater; 2021 Nov; 6(11):3865-3878. PubMed ID: 33937590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer
    Cheng Y; Chen Q; Guo Z; Li M; Yang X; Wan G; Chen H; Zhang Q; Wang Y
    ACS Nano; 2020 Nov; 14(11):15161-15181. PubMed ID: 33143424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled albumin nanoparticles for combination therapy in prostate cancer.
    Lian H; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7777-7787. PubMed ID: 29123392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
    Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
    Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
    Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy.
    Wang K; Zhang Y; Wang J; Yuan A; Sun M; Wu J; Hu Y
    Sci Rep; 2016 Jun; 6():27421. PubMed ID: 27263444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet membrane-based biochemotactic-targeting nanoplatform combining PDT with EGFR inhibition therapy for the treatment of breast cancer.
    Wan G; Chen X; Gou R; Guan C; Chen J; Wang Q; Wu W; Chen H; Zhang Q; Wang H
    Biomater Sci; 2024 Jan; 12(3):691-709. PubMed ID: 38099460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Reprogramming Armed Macrophage Membrane-Camouflaged Nanoplatform Enhances Bionic Targeted Drug Delivery to Solid Tumor for Synergistic Therapy.
    Ning P; Yao H; Du F; Yuan J; Xia Y; Yang P; Chen X; Rao Z; Wang X
    Mol Pharm; 2023 May; 20(5):2362-2375. PubMed ID: 36989419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
    Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
    J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photo-responsive prodrug nanoparticles for efficient cytoplasmic delivery and synergistic photodynamic-chemotherapy of metastatic triple-negative breast cancer.
    Jiao J; Lu H; Wang S
    Acta Biomater; 2021 May; 126():421-432. PubMed ID: 33774201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer.
    Valcourt DM; Dang MN; Day ES
    J Biomed Mater Res A; 2019 Aug; 107(8):1702-1712. PubMed ID: 30920169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A uPAR targeted nanoplatform with an NIR laser-responsive drug release property for tri-modal imaging and synergistic photothermal-chemotherapy of triple-negative breast cancer.
    Yu S; Huang G; Yuan R; Chen T
    Biomater Sci; 2020 Jan; 8(2):720-738. PubMed ID: 31777866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cascade Release Nanocarriers for the Triple-Negative Breast Cancer Near-Infrared Imaging and Photothermal-Chemo Synergistic Therapy.
    Li K; Li R; Zhou B; Chen J; Lan K; Zhan W; Chen D; Zhang T; Li X
    Front Oncol; 2021; 11():747608. PubMed ID: 34604092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional mesoporous silica nanoplatform based on silicon nanoparticles for targeted two-photon-excited fluorescence imaging-guided chemo/photodynamic synergetic therapy in vitro.
    Li S; Zhang Y; He XW; Li WY; Zhang YK
    Talanta; 2020 Mar; 209():120552. PubMed ID: 31892096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoplasmic reticulum-targeted NIR-II phototherapy combined with inflammatory vascular suppression elicits a synergistic effect against TNBC.
    Wan G; Chen X; Chen J; Gou R; Wang H; Liu S; Zhang M; Chen H; Wang D; Zhang Q
    Biomater Sci; 2023 Feb; 11(5):1876-1894. PubMed ID: 36692120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.